Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Spectranetics

This article was originally published in The Gray Sheet

Executive Summary

Spectranetics: Commences U.S. clinical trials the week of Nov. 6 of a "laser assisted pacemaker lead removal device." The firm says its "laser sheath" device is intended "to thread over an implanted pacing lead and ablate through scar tissue" to aid in the extraction of leads that have been implanted for at least one year. Trials for the device, which received investigational device exemption approval Oct. 19, will involve 318 patients at up to eight clinical sites. Spectranetics expects to complete enrollment by mid-1996...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT005030

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel